2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z

Rabbit Anti-Human Thymocyte Immunoglobulin (rATG) for Rescue Treatment of Chronic Antibody-Mediated Rejection (cAMR) After Pediatric Kidney Transplantation.

L. Pape, T. Ahlenstiel-Grunow, J. Drube, M. Kreuzer, C. Lerch, N. Kanzelmeyer, S. Wente, I. Hennies, Y. Cihan.
Race, Admissions, and Renal Transplant Waitlisting.

R. Lynch, R. Zhang, R. Patzer, C. Larsen, A. Adams.
Racial and Ethnic Disparities in Renal Replacement Therapy in Pediatric and Young Adult Population with End Stage Renal Disease (2005-2015).

R. George,¹ M. Basu,² L. Greenbaum,¹ A. Kirk,^2,3 N. Kutner,⁴ R. Patzer.^2,5
Racial Differences in Liver Cirrhosis-Related Mortality Among Patients with Model for End-Stage Liver Disease Sodium Score (MELDNa) ≤ 15.

K. Atiemo,¹ H. Maddur,¹ L. Zhao,¹ A. Skaro,² S. Montag,¹ L. VanWagner,¹ S. Goel,¹ A. Kho,¹ R. Kang,¹ J. Holl,¹ M. Abecassis,¹ J. Levitsky,¹ L. Kulik,¹ D. Ladner.¹
Racial Disparities in Self-Care Among Liver Transplant Candidates.

J. Wedd, J. Gander, K. Smith, S. Mujtaba, R. Subramanian, R. Parker, C. Reilly, R. Patzer.
Raising Awareness of the Importance of Exercise Training in Solid Organ Transplant: A Description of a Canadian Knowledge Dissemination Project.

T. Janaudis-Ferreira,¹ S. Mathur,² T. Blydt-Hansen.³
Rapamycin Directly Alters Human Endothelial Cell Alloimmunogenicity.

V. Bendersky,¹ H. Xu,² A. Kirk.²
Rapamycin Maintenance Therapy in Pediatric Liver Transplant Recipients Associated with Trend Toward Decreasing Th2 Cytokine Levels Compared to Tacrolimus Therapy.

R. Fischer,¹ A. Seng,² L. Gardner,² L. Steele,² L. Harvey,¹ H. Wasserkrug,¹ W. Andrews,¹ R. Hendrickson,¹ J. Daniel,¹ T. Yankee.²
Rapid Depletion of Circulating DSA and Treatment of Acute Antibody-Mediated Rejection with the Combination of CTLA-4Ig/Belatacept and Bortezomib in Mouse and Man.

J. Young,¹ A. Vannier,¹ G. Bumgardner,² A. Chong,¹ R. Pelletier.²
Rapid Deterioration of Pre-Transplant Kidney Function Requiring Dialysis Is a Prognostic Factor in Liver Transplant Alone.

S. Nagai,¹ M. Safwan,¹ K. Collins,¹ M. Rizzari,¹ D. Moonka,² A. Patel,³ K. Brown,² A. Yoshida,¹ M. Abouljoud.¹
Rapid Regression of Xanthomata After Orthotopic Liver Tranplantation for Alagille Syndrome.

N. Galvan,¹ P. Nguyen,¹ S. Koohmaraie,² R. Cotton,¹ A. Rana,¹ C. O'Mahony,¹ J. Goss.¹
RAS Inhibition Attenuates Urine Angiotensin II-Regulated Proteins Associated with Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.

Z. Mohammed-Ali,¹ S. Reid,³ P. Yip,¹ H. Cardinal,² M.-J. Hébert,² Y. Li,⁴ S. Kim,^1,3,4 A. Konvalinka.^1,3
Rates of CMV Infection in Kidney Transplant Recipients Who Received Subtherapeutic Valganciclovir Prophylaxis.

K. Belfield, E. Cohen, M. Malinis, A. Baghban.
Rates of Lost to Follow-Up Among Pediatric Heart, Kidney, and Liver Transplant Recipients.

W. Cherikh,¹ S. Bartosh,² R. Urban,¹ W. Mahle,³ G. Mazariegos,⁴ E. Brewer.⁵
Re-Evaluation of Imaging Studies in Patients with Hepatocellular Carcinoma at a Transplant Center Impacts Patient Care.

A. Kardashian, B. Madani, C. Frenette.
Readmission and Reoperation After Living Donor Hepatectomy.

S. Kapoor, B. Nath, V. Varma, S. Sable, A. Chauhan, V. Kumaran.
Readmissions After Liver Transplantation–They May Be Predictable, but Are They Inevitable?

B. O'Brien, C. Mardis, A. Mardis, J. Fleming, H. Meadows, N. Patel, N. Pilch, C. Perez, M. Sell, A. Rogers, I. Lee, J. McGillicuddy, K. Chavin, D. DuBay, D. Taber.
Reasons for Ineligibility for Kidney Donation by Race: Gap for Blacks Represented by Modifiable Factors, However Are Big Hurdles to Overcome.

D. Simpson,¹ M. Levine,¹ S. Amaral.²
Reasons for Racial Disparities in Living Donor Liver Transplants (LDLT).

M. McCauley,¹ D. Goldberg,¹ L. Nephew,¹ R. Kalman,¹ K. Forde.¹
Recipient iNOS Deficiency Reduces Spontaneous Kidney Allograft Acceptance by Accelerating Allograft Loss.

I. Aljabban, B. Jiang, C. Yang, D. Ndishabandi, R. White, P. Russell, J. Madsen, R. Colvin, A. Alessandrini.
Recognition of Islet Xenografts In Vivo by Non-Obese Diabetic (NOD) Insulin-Specific CD4 T Cells.

R. Gill, W. Dale, M. Crawford.
Recovery from Hypophosphatemia as a Predictor of Post-Operative Morbidity in Live Donor Hepatectomy.

O. Serrano,¹ D. Berglund,¹ V. Goduguchinta,¹ A. Reddy,¹ J. Menk,² D. Vock,³ V. Kirchner,¹ R. Kandaswamy,¹ A. Matas,¹ T. Pruett,¹ S. Chinnakotla.¹
Recurrence of IgA Nephropathy After Kidney Transplantation in Maintenance Steroids versus Steroid Avoidance Regimens: A UNOS/OPTN Analysis.

N. Leeaphorn, N. Garg, E. Khankin, F. Cardarelli, M. Pavlakis.
Recurrent HCC After Radiofrequency Ablation or Liver Resection Can Be Effectively Treated with Salvage Transplantation.

H. Muaddi,¹ D. Al-Adra,¹ J. Shaw,¹ D. Grant,¹ P. Greig,¹ I. McGilvray,¹ M. Cattral,¹ A. Wei,¹ C.-A. Moulton,¹ J. Kachura,² R. Beecroft,² M. Selzner,¹ A. Ghanekar,¹ S. Gallinger,¹ S. Cleary,¹ G. Sapisochin.¹
Recurrent Lupus Nephritis in a Multi-Ethnic Kidney Transplant Population.

I. Tang,¹ A. Koganti,¹ S. Setty,² S. Akkina.³
Redefining Pediatric Heart Status 1A and 1B Criteria: Results of Early Policy Evaluation.

W. Cherikh,¹ R. Davies,² Y. Cheng,¹ W. Mahle.³
Reduced Conversion from IgM Anti-HLA-DSA to IgG Anti-HLA-DSA in Belatacept-Treated vs. Cyclosporine-Treated Patients in BENEFIT and BENEFIT-EXT Trials.

M. Everly,¹ R. Townsend,² H. Gebel,³ R. Bray.³
Reduced Expression of Membrane Complement Regulatory Protein CD59 on Leukocytes Following Lung Transplantation.

L. Michielsen,¹ K. Budding,² D. Drop,² E. van de Graaf,³ T. Kardol-Hoefnagel,² M. Verhaar,¹ A. van Zuilen,¹ H. Otten.²
Reduced Racial Disparity in Outcomes of Kidney Transplant Recipients.

E. Iranpour, A. Tavabi, R. Garakani, R. Gohh, P. Morrissey, R. Saidi, R. Saidi.
Reduced Rituximab with Prophylactic Antibiotic Treatment Improves the Infectious Complications in Patients Undergoing ABO-Incompatible Living Donor Liver Transplantation.

S.-C. Hsu, A. Thorat, L.-B. Jeng, H.-R. Yang, P.-C. Li, C.-C. Yeh, T.-H. Chen, K.-S. Poon.
Reducing the Early Readmission Rates in Kidney Transplantation.

M. Tavares, M. Cristelli, L. Viana, I. Malbouisson, M. Paula, H. Silva Junior, J. Pestana.
Reduction in Kidney Offer Acceptance at Centers Undergoing Systems Improvement Agreements.

M. Bowring, L. Nicholas, A. Massie, D. Segev.
Reduction of Recipient Cell Cross-Dressing with Donor MHC Molecules Prolongs Allograft Survival in Mice.

J. Marino, H. Tector, B. Gonzalez-Nolasco, A. Lellouch, A. Harney, C. Cetrulo, Jr, J. Markmann, G. Benichou.
Refinement of an Old Faithful: A Standardized Flow Cytometry Approach to Measure Donor-Recipient Alloreactivity (a Pilot Study).

A. Halpin,¹ M. Sosniuk,¹ S. Urschel,¹ P. Campbell,² I. Larsen,¹ L. West.¹
Regional Variation in Liver Donor Utilization Across the U.S.

A. Friedman,¹ P. Bagavan,² S. Florman,³ H. Irving,¹ B. Samstein,⁴ B. Schleich.¹
Regulation of T Cell Migration by Specifically Targeting Lymphotoxin β Receptor (LTβR)-Mediated Non-Canonical NFkB Signaling.

W. Piao, Y. Xiong, C. Brinkman, J. Bromberg.
Regulatory T Cells Inhibit Plasmablast Formation and IgG Production by Tempering T Follicular Helper Cell Function.

P. Fadakar, C. Macedo, M. Yamada, K. Hadi, D. Metes.
Rejection of Human Kidney Allografts According to BANFF Classification Is Associated with a Chemokine-Enriched Protein Microenvironment in Biopsy Tssue.

C. Falk,¹ K. Daemen,¹ J. Keil,¹ F. Lehner,² H. Haller,³ J. Schmitz,⁴ J.-H. Bräsen,⁴ C. Blume.⁵
Relationship Between Mixed Chimerism and Tolerance in HLA-Matched and -Mismatched Recipients of Kidney and Hematopoietic Cell Transplants.

S. Busque, J. Scandling, J. Shizuru, R. Lowsky, A. Shori, J. Kent, E. Engleman, S. Strober.
Relationship of Liver Extraction Times to Early Allograft Dysfunction and Post-Transplant Kidney Injury.

D. Simpson, M. Gupta, C. McAllister, P. Porrett, D. Goldberg, M. Levine, K. Olthoff, A. Shaked, P. Abt.
Release of HMGB1 in Serum and Urine of Brain-Death Donors Is Associated with Delayed Graft Function (DGF) of the Kidney.

A. Zmijewska,¹ J. Chen,¹ J. Locke,² J. Zmijewski,¹ R. Mannon.¹
Reliability of Donor Kidney Biopsies from Time of Organ Recovery Compared to Immediate Post-Reperfusion Biopsies.

M. Barrett, A. Prater, E. Farkash, D. Christopher, D. Fritze, N. Matusko, R. Sung, K. Woodside.
Renal Function After Liver Transplantation Alone in Patients Meeting the Proposed UNOS Simultaneous Liver-Kidney (SLK) Criteria.

K. Roayaie,¹ E. Langewisch,² J. Burg,¹ C. Enestvedt,¹ E. Maynard,¹ D. Scott.¹
Renal Function Outcomes by HLA Mismatch in De Novo Kidney Transplant Recipients Receiving Everolimus PlusReduced-Dose Cyclosporine versus Mycophenolate Plus Standard-Dose Cyclosporine: 24-Month Subanalysis of A1202 Study.

K. Yoshida,¹ Y. Watarai,² K. Nakagawa,³ O. Kamisawa.⁴
Renal Function Outcomes of Hypertensive Living Kidney Donors (HLD) and Recipients of HLD Kidneys: Results of a Case-Control Study.

T. Pesavento,¹ A. Diez,¹ R. Pelletier,² U. Nori,¹ J. VonVisger.¹
Renal Function Variability Is a Significant and Independent Risk Factor for Graft Loss and Death in Kidney Transplantation.

D. Taber,¹ Z. Su,¹ A. Posadas,¹ D. Dubay,¹ C. Bratton,¹ J. McGillicuddy,¹ K. Chavin,¹ T. Srinivas,² S. Nadig,¹ V. Rohan,¹ P. Baliga.¹
Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation.

N. Lam,¹ M. Tonelli,² K. Lentine,³ B. Hemmelgarn,² F. Ye,¹ A. Bello,¹ S. Klarenbach.¹
Renal Function, Albuminuria, and the Risk of Death and Graft Loss After Kidney Transplantation.

N. Lam,¹ M. Tonelli,² K. Lentine,³ B. Hemmelgarn,² F. Ye,¹ K. Wen,¹ S. Klarenbach.¹
Renal Outcomes Following Intestinal Transplantation.

C. Puttarajappa,¹ A. Humar,¹ S. Hariharan,¹ R. Cruz Jr,¹ A. Ganoza,¹ D. Landsittel,^1,3 X. Gao,³ M. Bhattarai,¹ H. Sogawa.^1,2
Renal Secretion of Organic Anionic Drugs Is Compromised in Renal Transplant Patients.

H. Kalluri,¹ P. Sood,² P. Randhawa,^2,3 S. Hariharan,² A. Tevar,² A. Humar,² R. Venkataramanan.^1,2,3
Renal Transplant Outcomes in Primary FSGS Compared with Other Recipients: A National Review of the Irish Transplant Registry.

S. Cormican,¹ C. Kennedy,^1,2 P. O'Kelly,¹ B. Doyle,³ A. Dorman,³ P. Conlon.^1,2
Renal Transplant Patient Outcomes Following Plasmapheresis, Thymoglobulin, and Rituximab Induction for High Risk DSA Positive Recipients.

E. Lessmann,¹ M. Moaddab,¹ M. Manson,¹ A. Ram,² R. Kerman,² P. Jindra.²
Renal Transplant Recipients with Indication for Antiplatelet Therapy: Increased Risk for the Allograft?

T. Benko, M. Gottmann, S. Radunz, J. Treckmann, F. Saner, A. Paul, D. Hoyer.
Renal Transplantation to the Extraperitoneal Cavity in Children Weighing Less Than 15 kg Can Be Performed Safely.

K. Hata,¹ M. Okumi,¹ K. Ishizuka,² K. Unagami,³ T. Hirai,¹ T. Shimizu,¹ K. Omoto,¹ H. Ishida,¹ M. Hattori,² K. Tanabe.¹
Renoprotective Effects of Carbon Monoxide–Releasing Molecule 3 in Ischemia Reperfusion Injury and Cisplatin-Induced Toxicity.

Y. Yoon,¹ H. Lee,¹ K. Huh,² M. Kim,² S. Kim,² Y. Kim,² W. Han.¹
Repeat Biopsies After the Diagnosis of BK Virus Associated Nephropathy: Importance of Integrating Clinical and Pathological Findings.

C. Drachenberg,¹ J. Papadimitriou,¹ R. Ugarte,² M. Mavanur,² B. Thomas,² C. Cangro,² N. Costa,² M. Weir,² A. Haririan.²
Reproducibility of the Cobas CMV Test (cobas CMV) and Clinical Concordance with the Cobas Ampliprep / Cobas TaqMan CMV Test (CAP/CTM CMV).

P. Baum,¹ J. Yao,² A. Butcher,¹ P. Hemyari,¹ A. Valsamakis,³ S. Young.⁴
Respiratory Viral Infections Following Human Lung Transplant Can Induce Exosomes with Lung Self-Antigens, Kα1Tubulin and Collagen V.

M. Gunasekaran,¹ A. Limaye,² M. Sharma,¹ S. Biswas Roy,¹ S. Bansal,¹ R. Walia,¹ R. Bremner,¹ M. Smith,¹ T. Mohanakumar.¹
Restrictive Approach to Simultaneous Liver Kidney Transplantation.

S. Sultan, S. Fitzpatrick, T. Kozlowski, S. Malik, S. Hanish, D. Bruno, M. Weir, W. Hutson, R. Barth, J. LaMattina.
Results of Biliary Reconstruction with PTFE Graft in Liver Transplantation.

E. Ayvazoglu Soy,¹ G. Moray,¹ A. Torgay,² H. Ozdemir,³ M. Haberal.¹
Results of Stem Cell and Renal Transplantation in Patients with End Stage Renal Disease After Plasma Cell Dyscrasias.

C. Moliz,¹ B. Redondo,¹ M. Molina,¹ E. Morales,¹ E. Gonzalez,¹ J. Cabrera,² A. Andres.¹
Results of the Initial Phase of the Portable Organ Care System (OCS™) Liver PROTECT Pivotal Trial.

J. Markmann,¹ M. Ghobrial,³ J. Magliocca,⁴ A. Demetris,⁵ M. Abouljoud.²
Resumption of Standard Dose Immunosuppression Following Resolution of BK Viremia Does Not Lead to Viremia Recurrence.

K. Alquadan, A. Santos, M. Casey, T. Ozrazgat-Baslanti, S. Bozorgmehri, J. Gregg, K. Womer.
Retroactive Application of a New Risk Index for Living Donor Kidney Transplantation (LKDPI) to Renal Transplants in Veracruz, Mexico.

G. Martinez-Mier,^1,2 E. Soto-Miranda,¹ S. Avila-Pardo,² L. Budar-Fernandez,¹ M. Mendez-Lopez,¹ P. Moreno-Ley,¹ E. Aguilar-Sandoval,¹ G. Coello-Torres,³ F. Diaz-Trueba.³
Retroperitoneoscopic Living Donor Nephrectomy Safely Secures Excellent Graft Function.

T. Hirose, K. Hotta, D. Iwami, H. Sasaki, H. Higuchi, Y. Takada, N. Shinohara.
Retrospective Analysis of Kidney Transplant Recipients with Antibody-Mediated Rejection.

G. Piñeiro,¹ E. Desousa,¹ J. Villarreal,¹ M. Lozano,² J. Cid,² M. Sole,³ F. Oppenheimer,¹ F. Diekmann.¹
Retrospective Analysis of Multiple Hemodialysis Access Modalities.

V. Bowers,¹ H. Pearson,¹ J. Huang,¹ J. Leone,¹ A. Tanious,¹ K. Dawley,¹ E. Rogers,¹ V. Camba,² C. Albertson,² D. Lahiff,² T. Rashid,² J. Buggs.¹
Retrospective Review of Early versus Late Initiation of Oral Sildenafil for Right Ventricular Dysfunction in Post-Cardiac Transplant Surgery Patients.

P. Brown, B. Hamandi, M. McDonald, H. Ahmed, R. Whitty, D. Lowe.
Review of UK-Wide Practice of Pancreas Transplantation: Donor Selection, Back-Bench Preparation & Implantation Technique.

H. Sharma,¹ S. Bhutani,³ D. Vandellen,² T. Campbell,² R. Pararajasingham,² B. Forgacs,² A. Tavakoli,² P. Friend,⁴ T. Augustine,² R. Dhanda.²
Risk Analysis of Patients with Proven Coronary Artery Disease Undergoing Liver Transplant.

J. Balogh, K. Lunsford, D. Nguyen, E. Gravis, O. Cercio, C. Mobley, A. Saharia, S. Gordon Burroughs, A. Gaber, R. Ghobrial.
Risk and Prognosis of Developing Procedural Complications in Renal Allograft Biopsy, Including AVF and DVT.

H. Ide, K. Iwadoh, I. Nakajima, S. Fuchinoue.
Risk Factor for Hepatitis E Virus Infection Among Solid-Organ-Transplant Patients.

N. Kamar,¹ S. Lhomme,² F. Abravanel,² L. Esposito,¹ A. Hebral,¹ O. Marion,¹ A. Del Bello,¹ J. Izopet.²
Risk Factors and 2 Year Outcomes of Low Estimated Glomerular Filtration Rate in the Immediate Post-Operative Period for Living Kidney Donors.

H. Pahari,¹ S. Nagai,¹ K. Takahashi,¹ F. Tinney,² J. Denny,¹ L. Malinzak,¹ M. Rizzari,¹ K. Collins,¹ A. Yoshida,¹ M. Abouljoud,¹ D. Kim.¹
Risk Factors and Consequences of De Novo Anti-HLA Donor Specific Antibodies in Kidney Transplant Recipients: The Force Awakens.

B. Javaid, S. Rosen-Bronson, D. Li, M. Awwad, A. Gilbert, S. Ghasemian, J. Verbesey, P. Abrams, M. Grafals, J. Fenton, C. Cannon, J. Rapisura, J. Moore, M. Cooper.
Risk Factors and Outcomes of Intracardiac Thrombosis During Orthotopic Liver Transplantation.

W. Al-Darzi, M. El-Atrache, F. Georgie, O. Sadiq, S. Singla, C. Fernandez, R. Pompa, D. Galusca, A. Yoshida, S.-M. Jafri.
Risk Factors for Cryptococcal Disease in Transplant as Compared with Non-Transplant Patients: A Single Center Study.

O. Beaird,¹ O. Garner,² R. Humphries,² J. Schaenman.¹
Risk Factors for Hospital Readmission with Urinary Tract Infections (UTIs) Following Kidney Transplantation (KT).

E. Minja, S. Jackson, A. Matas.
Risk Factors for Polyomavirus Infection After Renal Transplantation: Introduction of the Protective Effect of Peritoneal Dialysis.

S. Hosseini-Moghaddam, Q. Xu, J. Kum, H. Alharbi, A. Jevnikar, M. John, G. Singh, S. Parsons, M. Edgar, P. Luke.
Risk Factors for Post-Transplant Lymphoproliferative Disorders in Epstein-Barr Virus Mismatch Lung Transplant Recipients.

A. Courtwright, P. Burkett, P. Camp, M. Divo, S. El-Chemaly, S. Keller, G. Mody, I. Rosas, S. Singh, H. Goldberg, H. Mallidi.
Risk Factors of Recurrence of Diabetic Nephropathy in Renal Trasplant.

B. Rodriguez Cubillo, M. Calvo, V. Lopez De La Manzanara, J. Bautista-Cañas, I. Perez-Flores, M. Moreno De La Higuera, N. Calvo Romero, A. Sanchez-Fructuoso.
Risk Factors of Treatment Failure in Antibody Mediated Rejection.

V. Pernin,¹ I. Szwarc,¹ T. Kanouni,² V. Garrigue,¹ J. Serre,¹ S. Delmas,¹ G. Mourad,¹ M. Le Quintrec.¹
Risk of Amiodarone and Permanent Pacemaker Placement After Heart Transplantation.

E. Kransdorf, M. Kittleson, J. Patel, T. Aintablian, R. Levine, B. Kearney, N. Musto, A. Hage, D. Geft, L. Czer, F. Esmailian, A. Trento, J. Kobashigawa.
Risk of Ischemic Biliary Injury Is Not Associated with Prolonged Hepatic Artery Ischemic Times During Liver Transplantation.

E. Armenia,¹ N. Schomaker,¹ A. Kalra,¹ J. Gralla,¹ A. Truesdale,¹ S. Biggins,² T. Nydam,¹ J. Burton.¹
Risk of Kidney Rejection Following Simultaneous Liver Kidney Transplantation.

S. Shah,¹ A. Suddle,¹ V. Aluvihare,¹ O. Shaw,³ C. Shaw,¹ N. Mamode,² C. Callaghan,² G. Koffman,² N. Heaton.¹
Risk of Major Bleeding in Solid Organ Transplant Recipients Taking Calcineurin Inhibitors Concomitantly with Direct Oral Anticoagulants Compared to Warfarin.

J. Hazelcorn, R. Yau, N. Sabagha, M. Moaddab, M. Manson.
Risk of Primary Central Nervous System Lymphoma in Solid Organ Transplant Recipients.

E. Engels, P. Mahale, M. Shiels.
Risk of Venous Thromboembolism After Lung Transplant.

R. Felkner,¹ A. Condon,² K. Rolling,³ M. Hayney.³
Risk Prediction Model for Delayed Graft Function in a Cohort of Brazilian Kidney Transplantation from Deceased Donors: What You See Is Not What You Get.

S. Costa,^1,2 T. Sandes-Freitas,^1,2 E. Daher,² R. Esmeraldo.¹
Risk Prediction Models for Living Donor Kidney Transplantation to Predict Donor and Recipient Mortality and Graft Loss.

M. Haller,¹ G. Mjøen,² H. Holdaas,³ G. Heinze,⁴ R. Oberbauer.⁵
Risks Associated with Recombinant IL2 Therapy in Renal Transplantation.

M. McGrath, S. Tripathi, A. Chandraker.
Rituximab Desensitization (DES) and Alemtuzumab Induction Significantly Reduced EBV Viremia and Post-Transplant Lymphoproliferative Disorder (PTLD) in HLA-Sensitized (HS) Kidney Transplant Patients.

B.-H. Shin,¹ S. Ge,¹ J. Mirocha,² D. Thomas,¹ E. Rodriguez,¹ C. Chao,¹ O. Galera,¹ A. Vo,¹ J. Choi,¹ A. Peng,¹ J. Kahwaji,¹ S. Jordan,¹ M. Toyoda.¹
Robotic Kidney Transplantation: Bakirkoy Experience.

S. Sahin,¹ V. Tugcu,¹ A. Yavuzsan,¹ F. Akbay,² S. Apaydin.²
Role of Chemokines in Resolution of BK Virus-Associated Nephropathy and Chronicity of Pathology Changes in Kidney Transplant Recipients.

J. Zuckerman, F. Palma Diaz, C. Magyar, B. Abdalla, E. Lum, S. Bunnapradist, T. Pham, G. Dannovitch, J. Veale, H. Gritsch, E. Reed, J. Schaenman.
Role of Donor-Derived Tissue Resident Memory T cells in Modulating Alloimmunity.

R. Crepeau, D. Liu, M. Ford.
Role of HMG CoA Reductase Inhibitors on Time to Development of Chronic Lung Allograft Dysfunction Post-Lung Transplant.

A. Szczepanik, A. Hulbert, H. Lee, C. Benedetti, L. Snyder, J. Byrns.
Role of Induction Therapy in Low Immune Risk Kidney Transplant Recipients: A Mate Kidney Analysis.

M. Sampaio, K. Sureshkumar.
Role of Protease Activated Receptor 1 and Sphingosine-1-Phospate Receptor 1 in Mice Hepatic Ischemia-Reperfusion Injury for Targeting Cell Signal Pathways of Activated Protein C.

T. Ito, N. Kuriyama, H. Kato, Y. Iizawa, A. Tanemura, Y. Murata, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, H. Sakurai, S. Isaji.
Routine Surveillance of Heart Transplant Recipients with Gene Expression Profiling: Lack of an Impact of Race on Outcomes.

J. Teuteberg,¹ M. Shullo,¹ D. Rinde-Hoffman,² M. Wigger,³ Y. Wang,⁴ T. Wolf,⁴ P. Arnold,⁴ J. Sninsky,⁴ P. Berman.²

Jump to: View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z